How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

In a significant turn of events, Intellia Therapeutics has announced the temporary suspension of dosing and patient screening in two late-stage studies of its groundbreaking gene-editing treatment ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read.

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors", that control how those genes are read.

Cancer therapies save lives but often cause neurologic damage, so we must recognize the full scope of neurotoxicity, from ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...